020 7713 0990
10 March 2017


Doctors from Britain, France and Denmark have joined a major international programme aimed to train them as leading researchers in haematology.

The group of 20 future expert haematologists has been announced by the American Society of Hematology.

The Translational Research Training in Hematology Programme, jointly run with the European Hematology Association, has named 20 participants for 2017.

These early-career haematologists will undertake the 'rigorous year-long training and mentoring experience that helps junior scientists build successful careers in translational haematologic research,' say the organisers.

The programme covers the fundamental principles related to translational research, including developing a hypothesis and testing that hypothesis in the laboratory by applying the scientific method.

This year's participants include Dr Alice Giustacchini of the Weatherall Institute of Molecular Medicine, Oxford, UK. Dr Giustacchini has previously worked on the genetic and cellular development of monoclonal B cell leukaemia.

Also joining the programme is Dr Cecile Thirant, of the Institut Gustave Roussy, Villejuif, France. She has carried out work on the role of astrocytes in malignant gliomas.

Dr Fazila Asmar, of Rigshospitalet, Copenhagen, Denmark, will also be taking part. One of the topics she has covered in earlier work is feedback regulation in aggressive chronic lymphocytic leukaemia.

President of the American Society of Hematology, Dr Kenneth Anderson, said: 'I'm pleased that we continue to offer this unique opportunity for junior scientists to learn the principles of translational research. This experience will give them the knowledge and support to turn their talents into discoveries that will count for patients.

'As a mentor myself, I am proud that the American Society of Hematology supports programmes that train and support the next generation of scientists.'


Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.